GSK
GSK’s shingles vaccine scores US approval
October 23, 2017Sales and Marketing FDA, GSK, Shingrix, pharma, shingles
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention …
GSK ranked at bottom of ‘good governance’ report
October 10, 2017Manufacturing and Production, Medical Communications Diageo, GSK, biotech, drugs, pharma, pharmaceutical
A new report emerging from the Institute of Directors placed UK pharma giant, GSK, in last place out of 103 …
New CMO hops onto Bicycle Therapeutics
September 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical
Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …
Witty, Ex-CEO of GSK, keeps busy with two new roles in two days
September 21, 2017Medical Communications : Pharma, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …
GSK gets FDA approval for key triple therapy inhaler
September 20, 2017Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical
The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.
GSK receives positive opinion for triple-therapy inhaler
September 15, 2017Medical Communications, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical
GSK, alongside its partner Innoviva, has announced that it has received a positive opinion from the EMA’s CHMP for its …
FDA panel gives GSK’s Shingrix unanimous approval
September 14, 2017Sales and Marketing GSK, Shingrix, biotech, drugs, pharma, pharmaceutical, shingles
The FDA’s advisory panel has given a strong signal that GSK’s Shingrix should not have too much difficulty getting full …
Merck KGaA to streamline business with $1bn healthcare sale
September 5, 2017Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …
Global shortage of hep B vaccine hits UK
August 9, 2017Manufacturing and Production, Research and Development GSK, MSD, biotech, drugs, hep b, hepatitis B, pharma, pharmaceutical
Only last week it was revealed that the UK would administer all babes with the hepatitis B vaccine to reduce …
Research into clinical trial transparency shows huge variation in standards
July 28, 2017Medical Communications, Sales and Marketing Abbott, GSK, biotech, clinical trials, drugs, pharma, pharmaceutical, transparency
A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …
GSK heads down digital path creating specific role for incomer
July 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical
GSK has created a whole new role to push the company to strengthen its digital, data and analytics strategy, with …
GSK chief reassured over ‘pragmatic’ Brexit approach
July 26, 2017Medical Communications Emma Walmsley, GSK, biotech, drugs, pharma, pharmaceutical
Amongst other announcements at its second quarter statement, GSK’s CEO, Emma Walmsley, gave a hint towards the British-based company’s desires …
GSK unveil appointment coup for board of directors
July 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, GSK, biotech, drugs, immunooncology, pharma, pharmaceutical
GSK continue its appointment spree with a particularly notable staff acquisition, with leading immuno-oncology scientist, Dr Laurie Glimcher, joining its …
GSK continues restructure by axing £350m Cumbria plant plans
July 21, 2017Manufacturing and Production, Medical Communications GSK, GlaxoSmithKline, UK, biotech, drugs, pharma, pharmaceuticals
Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …
Goodnight, Sweet Prince – GSK looks to sell on Horlicks business
July 19, 2017Sales and Marketing GSK, biotech, drugs, horlicks, pharma, pharmaceutical
GSK’s Emma Walmsley looks set to begin her rejig of the business, as she aims to offload part of its …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
